iSpecimen Inc. Files 8-K Report
Ticker: ISPC · Form: 8-K · Filed: Jan 16, 2025 · CIK: 1558569
Sentiment: neutral
Topics: 8-K, filing, disclosure
TL;DR
iSpecimen filed an 8-K on Jan 16, 2025, covering other events and financial exhibits.
AI Summary
On January 16, 2025, iSpecimen Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific financial figures or significant business changes were detailed in the provided excerpt.
Why It Matters
This filing serves as an official notification to the SEC and investors about significant company events or financial updates. It provides transparency regarding iSpecimen Inc.'s operational status.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- iSpecimen Inc. (company) — Registrant
- January 16, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-40501 (identifier) — Commission File Number
- 27-0480143 (identifier) — IRS Employer Identification No.
- 8 Cabot Road, Suite 1800 Woburn, MA 01801 (address) — Address of principal executive offices
- 781-301-6700 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for iSpecimen Inc.?
The filing is a Current Report (Form 8-K) pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting "Other Events" and "Financial Statements and Exhibits" as of January 16, 2025.
When was the earliest event reported in this filing?
The earliest event reported is dated January 16, 2025.
In which state is iSpecimen Inc. incorporated?
iSpecimen Inc. is incorporated in Delaware.
What is the principal executive office address for iSpecimen Inc.?
The principal executive office is located at 8 Cabot Road, Suite 1800, Woburn, MA 01801.
What is the Commission File Number for iSpecimen Inc.?
The Commission File Number for iSpecimen Inc. is 001-40501.
Filing Stats: 449 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2025-01-16 17:00:10
Key Financial Figures
- $0.0001 — h registered Common Stock, par value $0.0001 per share ISPC The Nasdaq Stock Mar
Filing Documents
- ea0227841-8k_ispecimen.htm (8-K) — 23KB
- ea022784102ex99-1_ispecimen.htm (EX-99.1) — 8KB
- 0001213900-25-004256.txt ( ) — 203KB
- ispc-20250116.xsd (EX-101.SCH) — 3KB
- ispc-20250116_lab.xml (EX-101.LAB) — 33KB
- ispc-20250116_pre.xml (EX-101.PRE) — 22KB
- ea0227841-8k_ispecimen_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On January 16, 2025, iSpecimen Inc. (the "Company") announced that it has secured suppliers for the flu-like human metapneumovirus (hMPV), positioning itself to address potential specimen demand for studying the disease and developing a vaccine amid growing concerns of a COVID-style pandemic. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated January 16, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 16, 2025 iSPECIMEN INC. By: /s/ Robert Bradley Lim Name: Robert Bradley Lim Title: Chief Executive Officer 2